Skip to content

Intraoperative Manipulatoin of Sutures Controls Long-term IOP after Trabeculectomy: A Randomized Controlled Trial

Intensive Regulation of Intraocular Pressure (IOP) by Intraoperative Manipulatoin of Sutures Controls the Long-term IOP after Trabeculectomy: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-10000880
Enrollment
Unknown
Registered
2010-06-01
Start date
2010-04-20
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary glaucoma

Interventions

A:Intensive regulation: standard trabeculectomy + intraoperative IOP control by manipulatoin of sutures
B:Control: standard trabeculectomy

Sponsors

Beijing Tongren Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients are diagnosed as primary open-angle glaucoma(POAG) or primay angle-closure glaucoma(PACG): glaucomatous optical nerve damage (such as narrowed optic disc edge, edge incisure, nerve fiber layer defect) and the corresponding repeatable visual field defect (GHT shows three consecutive relative scotomas (p=21mmHg; 3. Aged between 18 and 80 years old; 4. Patients who is going to receive initial trabeculectomy; 5. Written informed consent obtained.

Exclusion criteria

Exclusion criteria: 1. Secondary glaucoma (such as neovascular glaucoma , uveitis, external injury, lens expansion and etc.) or acute angle-closure glaucoma (including patients with past history of acute onset or definite onset signs); 2. Trabeculectomy combined with other procedures; 3. Patients having used systemic and local agents which may affect IOP for a long duration; 4. Patients having received the conjunctiva and intraocular surgeries; 5. Severe systemic diseases (such as stroke, tumor and etc.) that may affect follow-up plan or potentiality of moving to other areas in 6 months; 6. Patients with single eye; 7. Patients who are unable or unwilling to accept the long-term follow-up according to the project requirements; 8. Patients refusing to sign the informed consent.

Design outcomes

Primary

MeasureTime frame
The rate of IOP control;Intraocular pressure;

Secondary

MeasureTime frame
The incidence of postoperative complications;The grading of the filtering bleb;The incidence of postoperative intervention;

Countries

China

Contacts

Public ContactYuanbo LIANG
yuanboliang@126.com+86 010 58268289

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026